Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
11.28
+0.11 (0.98%)
At close: Dec 15, 2025, 4:00 PM EST
11.21
-0.07 (-0.62%)
After-hours: Dec 15, 2025, 7:17 PM EST
Avantor Market Cap
Avantor has a market cap or net worth of $7.69 billion as of December 15, 2025. Its market cap has decreased by -46.29% in one year.
Market Cap
7.69B
Enterprise Value
11.30B
1-Year Change
-46.29%
Ranking
Category
Stock Price
$11.28
Market Cap Chart
Since May 17, 2019, Avantor's market cap has increased from $4.93B to $7.69B, an increase of 56.08%. That is a compound annual growth rate of 6.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 7.69B | -46.37% |
| Dec 31, 2024 | 14.34B | -7.13% |
| Dec 29, 2023 | 15.44B | 8.60% |
| Dec 30, 2022 | 14.22B | -44.64% |
| Dec 31, 2021 | 25.68B | 57.75% |
| Dec 31, 2020 | 16.28B | 56.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 17, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |